-
公开(公告)号:US06884814B2
公开(公告)日:2005-04-26
申请号:US10316616
申请日:2002-12-11
申请人: Michael S. Malamas , Tam Q. Dinh , Iwan Gunawan , Michael D. Collini , Heather A. Harris , James C. Keith, Jr. , Leo M. Albert
发明人: Michael S. Malamas , Tam Q. Dinh , Iwan Gunawan , Michael D. Collini , Heather A. Harris , James C. Keith, Jr. , Leo M. Albert
IPC分类号: C07D261/20 , A61K31/42 , C07D263/54
CPC分类号: C07D261/20
摘要: This invention provides estrogen receptor modulators of formula I, having the structure wherein, R1, R2, and R3 are as defined in the specification, or a pharmaceutically acceptable salt thereof.
摘要翻译: 本发明提供式I的雌激素受体调节剂,其具有其中R 1,R 2,R 3和R 3的定义如 说明书或其药学上可接受的盐。
-
公开(公告)号:US07531564B2
公开(公告)日:2009-05-12
申请号:US11636947
申请日:2006-12-11
申请人: Michael S. Malamas , Robert E. McDevitt , Iwan Gunawan , Eric S. Manas , Michael D. Collini , Heather A. Harris , James C. Keith, Jr. , Leo M. Albert , C. Richard Lyttle
发明人: Michael S. Malamas , Robert E. McDevitt , Iwan Gunawan , Eric S. Manas , Michael D. Collini , Heather A. Harris , James C. Keith, Jr. , Leo M. Albert , C. Richard Lyttle
IPC分类号: A61K31/42
CPC分类号: C07D263/57 , C07D235/18 , C07D277/66 , C07D413/04 , C07D417/04
摘要: This invention provides estrogen receptor modulators of formula I, having the structure wherein R1, R2, R2a, R3, R3a, and R4, and X as defined in the specification, or a pharmaceutically acceptable salt thereof.
摘要翻译: 本发明提供式I的雌激素受体调节剂,其具有如说明书中所定义的R 1,R 2,R 2a,R 3,R 3a和R 4以及X或其药学上可接受的盐的结构。
-
公开(公告)号:US06960607B2
公开(公告)日:2005-11-01
申请号:US10316641
申请日:2002-12-11
IPC分类号: C07D231/56 , C07D261/20 , C07D263/56 , C07D263/57 , C07D263/54 , A61K31/42
CPC分类号: C07D263/57 , C07D231/56 , C07D261/20
摘要: This invention provides estrogen receptor modulators of formula I, having the structure wherein R1, R2, R3, and R4, and X as defined in the specification, or a pharmaceutically acceptable salt thereof.
摘要翻译: 本发明提供式I的雌激素受体调节剂,其具有其中R 1,R 2,R 3和R 4的结构 和/或其说明书中所定义的X或其药学上可接受的盐。
-
公开(公告)号:US07067524B2
公开(公告)日:2006-06-27
申请号:US10803612
申请日:2004-03-18
申请人: Richard E. Mewshaw , Richard J. Edsall , Cuijian Yang , Heather A. Harris , James C. Keith, Jr. , Leo M. Albert , Eric S. Manas
发明人: Richard E. Mewshaw , Richard J. Edsall , Cuijian Yang , Heather A. Harris , James C. Keith, Jr. , Leo M. Albert , Eric S. Manas
IPC分类号: A61K31/435 , A61K31/38 , A61K31/34 , A61K31/275 , A61K31/135
CPC分类号: C07C255/54 , C07C39/14 , C07C39/15 , C07C39/38 , C07C43/23 , C07C45/68 , C07C49/747 , C07C205/25 , C07C205/26 , C07C255/53
摘要: This invention provides estrogen receptor modulators of formula I, having the structure wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10, are as defined in the specification, or a pharmaceutically acceptable salt thereof.
摘要翻译: 本发明提供式I的雌激素受体调节剂,其具有其中R 1,R 2,R 3,R 4, R 5,R 6,R 7,R 8,R 9, / SUB和R 10,如说明书中所定义,或其药学上可接受的盐。
-
公开(公告)号:US06914074B2
公开(公告)日:2005-07-05
申请号:US10316640
申请日:2002-12-11
申请人: Richard E. Mewshaw , Richard J. Edsall , Cuijian Yang , Heather A. Harris , James C. Keith, Jr. , Leo M. Albert , Eric S. Manas
发明人: Richard E. Mewshaw , Richard J. Edsall , Cuijian Yang , Heather A. Harris , James C. Keith, Jr. , Leo M. Albert , Eric S. Manas
IPC分类号: A61P1/04 , A61K31/05 , A61K31/055 , A61K31/085 , A61K31/277 , A61P3/06 , A61P3/10 , A61P5/30 , A61P7/12 , A61P9/00 , A61P9/10 , A61P9/12 , A61P11/00 , A61P11/06 , A61P13/02 , A61P13/08 , A61P13/10 , A61P15/00 , A61P15/02 , A61P15/18 , A61P17/00 , A61P17/06 , A61P19/02 , A61P25/00 , A61P25/22 , A61P25/28 , A61P29/00 , A61P31/04 , A61P35/00 , A61P39/06 , C07C39/14 , C07C39/15 , C07C39/225 , C07C39/24 , C07C39/38 , C07C43/23 , C07C45/68 , C07C49/747 , C07C205/25 , C07C205/26 , C07C255/53 , C07C255/54 , A61K31/275 , C07C49/115 , C07C211/03 , C07C255/52
CPC分类号: C07C255/54 , C07C39/14 , C07C39/15 , C07C39/38 , C07C43/23 , C07C45/68 , C07C49/747 , C07C205/25 , C07C205/26 , C07C255/53
摘要: This invention provides estrogen receptor modulators of formula I, having the structure wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10, are as defined in the specification, or a pharmaceutically acceptable salt thereof.
摘要翻译: 本发明提供式I的雌激素受体调节剂,其具有其中R 1,R 2,R 3,R 4, R 5,R 6,R 7,R 8,R 9, / SUB和R 10,如说明书中所定义,或其药学上可接受的盐。
-
公开(公告)号:US06903238B2
公开(公告)日:2005-06-07
申请号:US10316446
申请日:2002-12-11
IPC分类号: A61K31/12 , A61K31/421 , A61K31/426 , A61K31/445 , A61K31/495 , A61K31/537 , A61K31/54 , C07C49/747 , C07C49/755 , C07C225/20 , C07C323/22 , C07C49/115
CPC分类号: A61K31/445 , A61K31/12 , A61K31/421 , A61K31/426 , A61K31/495 , A61K31/537 , A61K31/54 , C07C49/747 , C07C49/755 , C07C225/20 , C07C323/22 , C07C2602/08
摘要: This invention provides estrogen receptor modulators of formula I, having the structure R1, R2, and R3 are as defined in the specification, or a pharmaceutically acceptable salt thereof.
摘要翻译: 本发明提供式I的雌激素受体调节剂,其结构是R 1,R 2,R 3和R 3如说明书中所定义, 或其药学上可接受的盐。
-
公开(公告)号:US07235539B2
公开(公告)日:2007-06-26
申请号:US10348510
申请日:2003-01-21
申请人: Heather A. Harris , James C. Keith, Jr. , Leo M. Albert , Galina Vid , Sreenivasulu Megati , Christopher P. Miller
发明人: Heather A. Harris , James C. Keith, Jr. , Leo M. Albert , Galina Vid , Sreenivasulu Megati , Christopher P. Miller
IPC分类号: A61K31/56
CPC分类号: A61K31/57 , A61K31/56 , A61K31/704
摘要: This invention provides estrogen receptor modulators of formula I, having the structure wherein, R1 is hydrogen, alkyl of 1–6 carbon atoms, benzyl, alkylcarbonyl of 2–7 carbon atoms, or benzoyl; X is R2 is hydrogen, alkyl of 1–6 carbon atoms, benzyl, alkylcarbonyl of 2–7 carbon atoms, or benzoyl; R3 is hydrogen, alkyl of 1–6 carbon atoms, hydroxy, or alkoxy of 1–6 carbon atoms; a pharmaceutically acceptable salt thereof, a pharmaceutically acceptable salt of a sulfate ester of the hydroxyl group at the 3- or 17-position when R1 or R2 is hydrogen, or a glucuronide of the hydroxyl group at the 3- or 17-position when R1 or R2 is hydrogen.
摘要翻译: 本发明提供式I的雌激素受体调节剂,其具有以下结构:其中R 1是氢,1-6个碳原子的烷基,苄基,2-7个碳原子的烷基羰基或苯甲酰基; X是R 2是氢,1-6个碳原子的烷基,苄基,2-7个碳原子的烷基羰基或苯甲酰基; R 3是氢,1-6个碳原子的烷基,羟基或1-6个碳原子的烷氧基; 其药学上可接受的盐,当R 1或R 2为氢时在3-或17位羟基的硫酸酯的药学上可接受的盐,或当R 1或R 2为3-或17位时羟基的葡糖苷酸 或R2是氢。
-
公开(公告)号:US07022733B2
公开(公告)日:2006-04-04
申请号:US10828970
申请日:2004-04-21
申请人: Christopher P. Miller , Michael D. Collini , David H. Kaufman , Robert L. Morris , Robert R. Singhaus, Jr. , John W. Ullrich , Heather A. Harris , James C. Keith, Jr. , Leo M. Albert , Rayomand J. Unwalla
发明人: Christopher P. Miller , Michael D. Collini , David H. Kaufman , Robert L. Morris , Robert R. Singhaus, Jr. , John W. Ullrich , Heather A. Harris , James C. Keith, Jr. , Leo M. Albert , Rayomand J. Unwalla
IPC分类号: A61K31/343
CPC分类号: C07D307/80 , C07D405/06 , C07D413/04
摘要: This invention provides estrogen receptor modulators of formula I, having the structure wherein R, R′, A, A′, X, Y, and Y are as defined in the specification, or a pharmaceutically acceptable salt thereof.
-
公开(公告)号:US06835745B2
公开(公告)日:2004-12-28
申请号:US10340425
申请日:2003-01-10
申请人: Richard D. Coghlan , William F. Fobare , Heather A. Harris , James C. Keith, Jr. , Leo M. Albert
发明人: Richard D. Coghlan , William F. Fobare , Heather A. Harris , James C. Keith, Jr. , Leo M. Albert
IPC分类号: A61K3138
CPC分类号: A61K31/34 , A61K31/165 , A61K31/277 , A61K31/381 , C07D327/08 , C07D333/12
摘要: This invention provides estrogen receptor modulators of formula I, having the structure wherein, R1, R2, R3, X, and Y are as defined in the specification, or a pharmaceutically acceptable salt thereof.
摘要翻译: 本发明提供式I的雌激素受体调节剂,其具有结构,其中R 1,R 2,R 3,X和Y如说明书中所定义,或其药学上可接受的盐。
-
公开(公告)号:US06774248B2
公开(公告)日:2004-08-10
申请号:US10320207
申请日:2002-12-16
申请人: Christopher P. Miller , Michael D. Collini , David H. Kaufman , Robert L. Morris , Robert R. Singhaus, Jr. , John W. Ullrich , Heather A. Harris , James C. Keith, Jr. , Leo M. Albert , Rayomand J. Unwalla
发明人: Christopher P. Miller , Michael D. Collini , David H. Kaufman , Robert L. Morris , Robert R. Singhaus, Jr. , John W. Ullrich , Heather A. Harris , James C. Keith, Jr. , Leo M. Albert , Rayomand J. Unwalla
IPC分类号: A61K3134
CPC分类号: C07D307/80 , C07D405/06 , C07D413/04
摘要: This invention provides estrogen receptor modulators of formula I, having the structure wherein R, R′, A, A′, X, Y, and Y are as defined in the specification, or a pharmaceutically acceptable salt thereof.
摘要翻译: 本发明提供式I的雌激素受体调节剂,其具有其中R,R',A,A',X,Y和Y如说明书中所定义的结构,或其药学上可接受的盐。
-
-
-
-
-
-
-
-
-